News

Accreditation for Cardiovascular Excellence (ACE) has just released the first-ever electrophysiology (EP) and implantable cardioverter defibrillator (ICD) standards for accreditation. Driven by the latest available clinical evidence, the EP and ICD standards are a comprehensive review of interventional procedures in patients and adults with heart rhythm disorders.

Home May 15, 2015
Home
News

A new study reports that antiplatelet drug ticagrelor (Brilinta) works faster and is more effective in blocking platelet activity in low-risk patients with acute coronary syndrome (ACS) than clopidogrel. The study was presented as a late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2015 Scientific Sessions in San Diego.

Home May 14, 2015
Home
News

Combining statins for low-density lipoprotein (LDL) and calcium channel antagonists for blood pressure reduces harmful coronary plaque, according to a study presented at the Society of Cardiovascular Angiography and Interventions (SCAI) 2015 Scientific Sessions in San Diego. The study, presented as a late-breaking clinical trial, found aggressive medication therapy does not provide additional benefit compared to standard cholesterol and blood pressure-lowering therapy.

Home May 14, 2015
Home
HRS, National Stroke Association, atrial fibrillation, AF, misperceptions, paper
Feature

A white paper published by the Heart Rhythm Society (HRS) and National Stroke Association characterizes the impact of stroke on patients with atrial fibrillation (AF) and presents common barriers to effective communication among patients, caregivers, and physicians. The white paper, Impact of Stroke in Atrial Fibrillation, is a collaborative effort between the two organizations to improve education and diminish stroke risk in patients with AF.

Home May 14, 2015
Home
News | Enterprise Imaging

ScImage announced that it has received validation for its PICOM365 enterprise picture archiving and communication system (PACS) within the framework of the Veterans Health Administration (VHA) system. The solution was validated as “Supported for HL7 Communication” with VHA’s VistA Imaging system.

Home May 14, 2015
Home
News

A new independent evaluation report from the Department of Health and Human Services showed that the Pioneer Accountable Care Organization (ACO) payment model has generated substantial savings to Medicare in just two years. Additionally, the independent Office of the Actuary in the Centers for Medicare & Medicaid Services (CMS) has certified that this patient care model is the first to meet the stringent criteria for expansion to a larger population of Medicare beneficiaries.

Home May 13, 2015
Home
News

Pressure to create alternative payment models has led to a significant increase in provider interest in partnering with Premier Inc. to develop and implement population health management strategies.

Home May 13, 2015
Home
Cath lab, cath lab management with multiple speciality users, EP, cardiology, IR, endovascular procedures
Feature | Cardiovascular Business | Dave Fornell

Most community hospitals with cardiac catheterization labs share these facilities with multiple, non-interventional cardiology users, which can be challenging to manage various specialties’ needs. Beyond percutaneous coronary interventions (PCI), these labs are frequently shared with electrophysiologists (EP), vascular surgeons conducting endovascular repairs and interventional radiologists (IR) performing an array of non-coronary vascular or peripheral interventions.

Home May 13, 2015
Home
News

Fujifilm Medical Systems U.S.A. said it completed its acquisition of TeraMedica Inc., a global healthcare informatics company and a provider of vendor neutral, enterprise solutions. The acquisition will allow Fujifilm to offer the market a leading vendor neutral archiving (VNA) technology.

Home May 13, 2015
Home
News | Telecardiology

At Nebraska Medicine, technology innovations bring with them opportunities to enhance patient care. The ability to integrate patient images with synchronized and simultaneous audio and video has Nebraska Medicine’s telehealth coordinator Kyle Hall looking at new ways to implement telehealth and mobile devices, such as iPads and Google Glass, at clinics and hospitals.

Home May 13, 2015
Home
Technology

Abbott and GE Healthcare announced an agreement that will bring real-time, patient-specific data about the heart's electrical activity to cardiac electrophysiology labs. The goal of the collaboration is to speed up the diagnosis of the sources of atrial fibrillation and other heart rhythm disorders.

Home May 13, 2015
Home
News

For the first time, cardiac catheterization laboratory stakeholders now have quality metrics that confirm the value of Accreditation for Cardiovascular Excellence (ACE) accreditation. Three new studies validating the benefits of ACE accreditation were presented during the 2015 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions in San Diego, California, May 6-9.

Home May 12, 2015
Home
Feature

A team from Stanford University School of Medicine has developed and combined new paper and flexible polymer substrates with special sensing devices for rapid and accurate detection of pathogens such as HIV and other biotargets. These novel technologies offer the type of robust, simple, and inexpensive biosensing systems required to provide point-of-care healthcare in remote areas, where there is minimal diagnostic infrastructure or equipment and a lack of trained medical technicians.

Home May 12, 2015
Home
News

Cardiovascular Systems Inc. (CSI) featured two-year data from its ORBIT II study of the company’s Diamondback 360 coronary orbital atherectomy system (OAS) in a late-breaking presentation at the 2015 Society for Cardiovascular Angiography and Interventions (SCAI) conference. Diamondback 360 is a U.S. Food and Drug Administration (FDA)-approved atherectomy technology indicated for the treatment of severely calcified lesions.

Home May 12, 2015
Home
News

CardiAQ Valve Technologies announced U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) approval for a feasibility study of its second generation transfemoral (TF) and transapical (TA) transcatheter mitral valve implantation systems. The study will enroll up to 20 patients (10 TF and 10 TA) and multidisciplinary physician teams at select U.S. sites will start enrollment once hospital approvals and agreements are in place.

Home May 12, 2015
Home
Subscribe Now